These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29349833)

  • 1. A systematic assessment of key design and performance characteristics of drug exposure registries requested by the U.S. Food and Drug Administration.
    Zhao Y; Pinnow E; Major JM
    Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):299-306. PubMed ID: 29349833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis.
    Wallach JD; Egilman AC; Dhruva SS; McCarthy ME; Miller JE; Woloshin S; Schwartz LM; Ross JS
    BMJ; 2018 May; 361():k2031. PubMed ID: 29794072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of success.
    Winiecki SK; Tejero-Taldo MI; Avant D; Murphy D; McMahon AW
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):602-5. PubMed ID: 26687996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements.
    Wallach JD; Ross JS; Naci H
    Clin Trials; 2018 Jun; 15(3):219-229. PubMed ID: 29871509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008.
    Moore TJ; Furberg CD
    JAMA Intern Med; 2014 Jan; 174(1):90-5. PubMed ID: 24166236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements.
    Jones WS; Krucoff MW; Morales P; Wilgus RW; Heath AH; Williams MF; Tcheng JE; Marinac-Dabic JD; Malone ML; Reed TL; Fukaya R; Lookstein RA; Handa N; Aronow HD; Bertges DJ; Jaff MR; Tsai TT; Smale JA; Zaugg MJ; Thatcher RJ; Cronenwett JL
    J Vasc Surg; 2018 Feb; 67(2):637-644.e30. PubMed ID: 29389426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of FDA safety-related drug label changes in 2010.
    Lester J; Neyarapally GA; Lipowski E; Graham CF; Hall M; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):302-5. PubMed ID: 23280652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999.
    Cross J; Lee H; Westelinck A; Nelson J; Grudzinskas C; Peck C
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):439-46. PubMed ID: 12426927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection.
    Gelperin K; Hammad H; Leishear K; Bird ST; Taylor L; Hampp C; Sahin L
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):208-214. PubMed ID: 28028914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Variability in Patient Exposure During Premarket Clinical Development on Postmarket Safety Outcomes.
    Cherkaoui S; Pinnow E; Bulatao I; Day B; Kalaria M; Brajovic S; Dal Pan G
    Clin Pharmacol Ther; 2021 Dec; 110(6):1512-1525. PubMed ID: 34057195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond indications: postmarket surveillance and the importance of expanded and off-label use of transcatheter devices in structural and congenital interventions.
    McElhinney DB
    Circ Cardiovasc Interv; 2012 Dec; 5(6):739-40. PubMed ID: 23250968
    [No Abstract]   [Full Text] [Related]  

  • 15. US Food and Drug Administration documents can provide unpublished evidence relevant to systematic reviews.
    McDonagh MS; Peterson K; Balshem H; Helfand M
    J Clin Epidemiol; 2013 Oct; 66(10):1071-81. PubMed ID: 23856190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy exposure registries.
    Kennedy DL; Uhl K; Kweder SL
    Drug Saf; 2004; 27(4):215-28. PubMed ID: 15003034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013.
    Bouvy JC; Blake K; Slattery J; De Bruin ML; Arlett P; Kurz X
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1442-1450. PubMed ID: 28345151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.
    Köhler M; Haag S; Biester K; Brockhaus AC; McGauran N; Grouven U; Kölsch H; Seay U; Hörn H; Moritz G; Staeck K; Wieseler B
    BMJ; 2015 Feb; 350():h796. PubMed ID: 25722024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centralized access to cancer registries.
    Deapen D
    Ann Epidemiol; 2016 Nov; 26(11):754-756. PubMed ID: 27837787
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.